Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Treace Medical Concepts Inc (TMCI)

Treace Medical Concepts Inc (TMCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Treace Medical Concepts Announces Successful First Cases of SpeedPlateâ„¢ MicroQuadâ„¢ Implants for Minimally Invasive Bunion Surgery

Treace Medical Concepts reports successful initial cases of its SpeedPlateâ„¢ MicroQuadâ„¢ implants for minimally invasive bunion surgeries.Quiver AI SummaryTreace Medical Concepts, Inc. has announced...

TMCI : 7.08 (+1.58%)
Treace Announces First Surgical Cases Utilizing the SpeedPlateâ„¢ MicroQuadâ„¢ Implant

TMCI : 7.08 (+1.58%)
Treace Medical Concepts Announces Successful First Cases of IntelliGuide™ PSI Technology with Adductoplasty® System for Bunion Treatment

Treace Medical Concepts announced successful use of IntelliGuide™ PSI technology with Adductoplasty® for personalized midfoot deformity corrections.Quiver AI SummaryTreace Medical Concepts, Inc. has...

TMCI : 7.08 (+1.58%)
Treace Announces First Cases Utilizing RedPoint™ Intelliguide™ Patient Specific Instrumentation with the Adductoplasty® System for Correction of Midfoot Deformities

TMCI : 7.08 (+1.58%)
Treace Medical Concepts Appoints Guy Guglielmino as Chief Commercial Officer to Drive Innovation and Growth

Treace Medical Concepts appoints Guy Guglielmino as Chief Commercial Officer to enhance innovation and growth in bunion treatment.Quiver AI SummaryTreace Medical Concepts, a medical technology firm focused...

TMCI : 7.08 (+1.58%)
Treace Appoints Guy Guglielmino as Chief Commercial Officer

TMCI : 7.08 (+1.58%)
Treace Medical Concepts to Participate in Fireside Chat at Stifel 2024 Healthcare Conference

Treace Medical Concepts executives will speak at the Stifel Healthcare Conference on November 19, 2024, via webcast.Quiver AI SummaryTreace Medical Concepts, Inc. announced that CEO John T. Treace and...

TMCI : 7.08 (+1.58%)
Treace Announces Participation at Stifel 2024 Healthcare Conference

TMCI : 7.08 (+1.58%)
Treace Medical Concepts: Q3 Earnings Snapshot

Treace Medical Concepts: Q3 Earnings Snapshot

TMCI : 7.08 (+1.58%)
Treace Medical Concepts Reports Third Quarter 2024 Financial Results

TMCI : 7.08 (+1.58%)

Barchart Exclusives

Bank of America Says to Crash Proof Your Portfolio With These 3 ‘Magnificent 7’ Stocks
Anticipating a correction, BofA analysts see these tech giants as safe bets. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar